The public health impact of the MiniMed Continuous Glucose Monitoring System (CGMS®) - An assessment of the literature

Diabetes Technology and Therapeutics

Volumn 6, Issue 4, 2004, Pages 518-522

  Tavris, Dale R ^a   Shoaibi, Azadeh ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

BLOOD GLUCOSE MONITORING; CALIBRATION; CORRELATION COEFFICIENT; DIABETES CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PUBLIC HEALTH; RELIABILITY; REVIEW;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; HUMANS; MONITORING, AMBULATORY; PUBLIC HEALTH; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 4344699878     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/1520915041705956     Document Type: Review

References (27)

1. Food and Drug Administration: Summary of Safety and Effectiveness Data for the MiniMed Continuous Glucose Monitoring System (CGMS). Publication No. PMA P980022. Rockville, MD: Food and Drug Administration, 1999.
2. Bode BW, Gross TM, Thorton KR, Mastrototaro JJ: Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999;46 183-190.
3. Chase PH, Kim LM, Owen SL, MacKenzie TA, Klingensmith GJ, Murtfeldt R, Garg SK: Continuous subcutaneous searchsearchglucose monitoring in children with type 1 diabetes. Pediatrics 2001;107:222-226.
4. Kaufman FR: Role of continuous glucose monitoring in pediatric patients. Diabetes Technol Ther 2000;2 (Suppl 1):S49-S52.
5. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV: Limitations of conventional methods of self-monitoring of blood glucose. Diabetes Care 2001;24:1858-1862.
6. Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, Tamborlane WV: Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care 2002;25:889-893.
7. Mastrototaro JJ: The MiniMed Continuous Glucose Monitoring System. Diabetes Technol Ther 2000;2 (Suppl 1):S13-S18.
8. Metzger M, Leibowitz G, Wainstein J, Glaser B, Raz I: Reproducibility of glucose measurements using the glucose sensor. Diabetes Care 2002;25:1185-1191.
9. Steil GM, Rebrin K, Mastrototaro J, Bernaba B, Saad MF: Determination of plasma glucose excursions with a subcutaneous glucose sensor. Diabetes Technol Ther 2003;5:27-31.
10. Gross TM, Ter Veer A: Continuous glucose monitoring in previously unstudied population subgroups. Diabetes Technol Ther 2000;2(Suppl 1):S27-S34.
11. Gross TM, Mastrototaro JJ: Efficacy and reliability of the Continuous Glucose Monitoring System. Diabetes Technol Ther 2000;2(Suppl 1):S19-S26.
12. Gross TM, Bode BW, Einhorn D, Kayne DM, Reed C, White NH, Mastrototaro JJ: Performance evaluation of the MiniMed Continuous Glucose Monitoring System during patient home use. Diabetes Technol Ther 2000;2:49-56.
13. Guerci B, Floriot M, Bohme P, Durain D, Benichou M, Jellimann S, Drouin P: Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Diabetes Care 2003;26:582-589.
14. Sachedina N, Pickup JC: Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycemic control in type 1 diabetic subjects. Diabet Med 2003;20:1012-1015.
15. Djakoure-Platonoff C, Radermecker R, Reach G, Slama G, Selam JL: Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions. Diabetes Metab 2003;29:159-162.
16. McGowan K, Thomas W, Moran A: Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 2002;25:1499-1503.
17. Cheyne EH, Cavan DA, Kerr D: Performance of a continuous glucose monitoring system during controlled hypoglycemia in healthy volunteers. Diabetes Technol Ther 2002;4:607-613.
18. The Diabetes Research in Children Network (DirectNet) Study Group: The accuracy of the CGMS in children with type 1 diabetes: results of the Diabetes Research in Children Network (DirecNet) accuracy study. Diabetes Technol Ther 2003;5:781-789.
19. Weinzimer SA, Delucia MC, Boland EA, Steffen A, Tamborlane WV: Analysis of continuous glucose monitoring data from non-diabetic and diabetic children: a tale of two algorithms. Diabetes Technol Ther 2003;5:375-380.
20. The Diabetes Research in Children Network (DirectNet) Study Group: Accuracy of the GlucoWatch G2 Biographer and the Continuous Glucose Monitoring System during hypoglycemia. Diabetes Care 2004;27:722-726.
21. 1c in pediatric type 1 diabetic patients. Diabetes Care 2002;25:1840-1844.
22. 1c. Ann Clin Biochem 2002;39:516-517.
23. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P: A pilot study of the Continuous Glucose Monitoring System-clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 2001;24:2030-2034.
24. Chico A, Vidal-Rios P, Subira M, Novials A: The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003;26:1153-1157.
25. Ludvigsson J, Hanas R: Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003;111:933-938.
26. Cheyne E, Kerr D: Making 'sense' of diabetes: using a continuous glucose sensor in clinical practice. Diabetes Metab Res Rev 2002;18(Suppl 1):S43-S48.
27. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes and hypertension. N Engl J Med 1993;329:977-986.